U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ALIROCUMAB
PP0SHH6V16
US Approved Rx (2015)
First approved in 2015
General
Names
13
Classification
3
Identifiers
17
Subunits
4
Related Substances
1
ALIROCUMAB
PP0SHH6V16
US Approved Rx (2015)
First approved in 2015
General
Approval Year
2015
472
Names
13
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
PRALUENT
Preferred Name
English
ALIROCUMAB
Official Name
English
ALIROCUMAB [USAN]
Common Name
English
REGN-727
Code
English
REGN727
Code
English
Showing 1 to 5 of 13 entries
Previous
1
2
3
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Other lipid modifying agents
ATC
CARDIOVASCULAR SYSTEM
LIPID MODIFYING AGENTS
LIPID MODIFYING AGENTS, PLAIN
Other lipid modifying agents
alirocumab
WHO-ATC
C10AX14
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
PCSK9 Inhibitor
[EPC]
NDF-RT
N0000191731
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of homozygous familial hypercholesterolemia
FDA ORPHAN DRUG
580617
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
17
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
USAN
YY-133
PRIMARY
DAILYMED
PP0SHH6V16
PRIMARY
FDA UNII
PP0SHH6V16
PRIMARY
SMS_ID
100000159811
PRIMARY
EVMPD
SUB170596
PRIMARY
Showing 1 to 5 of 17 entries
Previous
1
2
3
4
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
PP0SHH6V16
ALIROCUMAB
